CHMP Backs Emtricitabine/Tenofovir Alafenamide for HIVCHMP Backs Emtricitabine/Tenofovir Alafenamide for HIV

The combo, called Descovy, is an alternative treatment option to Gilead's tenofovir disoproxil fumarate (Viread) and is expected to have similar efficacy, the committee said. International Approvals
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Alert Source Type: news